Lanzamiento Enero 2027

Ensayo controlado aleatorizado2011Financiación no declarada

Creatine in type 2 diabetes: a randomized, double-blind, placebo-controlled trial

Gualano B, DE Salles Painneli V, Roschel H, Artioli GG, Neves M, De Sá Pinto AL, Da Silva ME, Cunha MR, Otaduy MC, Leite Cda C, Ferreira JC, Pereira RM, Brum PC, Bonfá E, Lancha AH

Medicine and science in sports and exercise · 75 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2010-09-29 · Med Sci Sports Exerc · vol. 43 · número 5 · págs. 770–778
Editorial
Lippincott Williams & Wilkins
Citado
99 citas · más que el 81% de estudios similares · 1.6× el promedio de su campo
Referencias
31 trabajos
Acceso
De pago
Áreas de investigación
Muscle metabolism and nutrition · Diabetes Management and Research · Natural Antidiabetic Agents Studies
Palabras clave
creatine supplementation, type 2 diabetes, glycemic control, exercise training, HbA1c, insulin sensitivity, GLUT4 translocation, glucose tolerance, insulin, C-peptide
MeSH
humans, diabetes mellitus, type 2, creatine, blood glucose, lipids, phosphocreatine, blotting, western, exercise, double-blind method, oxygen consumption, energy intake, dietary supplements, middle aged, female, male, glycated hemoglobin

15 autores

  • Bruno Gualano🇧🇷Universidade de São Paulo
  • VITOR DE SALLES PAINNELI🇧🇷Universidade de São Paulo
  • Hamilton Roschel🇧🇷Universidade de São Paulo
  • Guilherme Giannini Artioli🇧🇷Universidade de São Paulo
  • Manoel Neves🇧🇷Universidade de São Paulo
  • Ana Lúcia de Sá Pinto🇧🇷Universidade de São Paulo
  • Maria Elizabeth Rossi da Silva🇧🇷Universidade de São Paulo
  • Maria Rosária Cunha🇧🇷Universidade de São Paulo
  • Maria Concepción García Otaduy🇧🇷Universidade de São Paulo
  • Cláudia da Costa Leite🇧🇷Universidade de São Paulo
  • Julio Cesar Batista Ferreira🇧🇷Universidade de São Paulo
  • Rosa Maria Rodrigues Pereira🇧🇷Universidade de São Paulo
  • Patrı́cia C. Brum🇧🇷Universidade de São Paulo
  • Eloísa Bonfá🇧🇷Universidade de São Paulo
  • Antônio Herbert Lancha🇧🇷Universidade de São Paulo

Resumen

El texto original del estudio, en el idioma en que se publicó.

Unlabelled

Creatine supplementation improves glucose tolerance in healthy subjects.

Purposes

The aim was to investigate whether creatine supplementation has a beneficial effect on glycemic control of type 2 diabetic patients undergoing exercise training.

Methods

A 12-wk randomized, double-blind, placebo-controlled trial was performed. The patients were allocated to receive either creatine (CR) (5 g·d) or placebo (PL) and were enrolled in an exercise training program. The primary outcome was glycosylated hemoglobin (HbA1c). Secondary outcomes included the area under the curve of glucose, insulin, and C-peptide and insulin sensitivity indexes. Physical capacity, lipid profile, and GLUT-4 protein expression and translocation were also assessed.

Results

Twenty-five subjects were analyzed (CR: n=13; PL: n=12). HbA1c was significantly reduced in the creatine group when compared with the placebo group (CR: PRE=7.4 ± 0.7, POST=6.4 ± 0.4; PL: PRE=7.5 ± 0.6, POST=7.6 ± 0.7; P=0.004; difference=-1.1%, 95% confidence interval=-1.9% to -0.4%). The delta area under the curve of glucose concentration was significantly lower in the CR group than in the PL group (CR=-7790 ± 4600, PL=2008 ± 7614; P=0.05). The CR group also presented decreased glycemia at times 0, 30, and 60 min during a meal tolerance test and increased GLUT-4 translocation. Insulin and C-peptide concentrations, surrogates of insulin sensitivity, physical capacity, lipid profile, and adverse effects were comparable between the groups.

Conclusions

Creatine supplementation combined with an exercise program improves glycemic control in type 2 diabetic patients. The underlying mechanism seems to be related to an increase in GLUT-4 recruitment to the sarcolemma.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.